Mounjaro®
Starting from £179.99/mo
Start journey Learn moreHair thinning after starting a semaglutide-based medicine is real, and it has a name: telogen effluvium. It affects a minority of people on Wegovy and is almost always temporary, linked to rapid weight loss rather than the drug itself. Here is what the evidence shows, what to watch for, and when to act.
Semaglutides do not appear to damage hair follicles directly. The NHS medicines information for semaglutide lists hair loss as an uncommon side effect, meaning it affects fewer than 1 in 100 people. The more likely cause is the physical stress the body experiences during significant, rapid calorie restriction — the same mechanism seen after major surgery, illness, or extreme dieting. Because semaglutide is a prescription-only medicine, a prescriber reviews your full health picture before treatment begins, which is the right place to flag any existing hair or nutritional concerns.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Telogen effluvium works on a delay. When the body registers a significant stress (in this case, a sustained calorie deficit driven by reduced appetite on semaglutide) it can shift a larger-than-usual proportion of hairs from the growth phase into the resting phase. Those hairs then fall out roughly two to four months later, which is why many people notice thinning not in the first weeks of treatment but later, once weight loss is already underway.
The practical upshot: if you started semaglutide three months ago and are now seeing more hair in the shower drain, the timing fits. Run your fingers lightly across your scalp and look at the parting in good light, diffuse thinning across the whole scalp is typical of telogen effluvium; a defined bald patch or recession line suggests something else entirely and warrants a GP appointment regardless of what medicines you're taking.
People who lose weight very quickly, restrict calories heavily alongside the medicine, or arrive at treatment already low in iron, ferritin, zinc or vitamin D carry a higher risk. Semaglutide suppresses appetite powerfully, and eating less makes it easier to fall short on protein and key micronutrients without noticing. For a fuller picture of how the medicine works and its broader side-effect profile, that page covers the main categories in detail.
Nutrition matters more here than most people expect. Hair follicles are metabolically active and prioritised low by the body when calories or specific nutrients are scarce. Prioritising protein at each meal, eating adequate calories for your activity level, and checking that your diet includes enough iron-rich foods are practical steps that cost nothing and take five minutes of meal planning.
A simple thing you can do right now: check the NHS's guidance on healthy weight and diet basics and use it as a prompt to review whether your protein intake has quietly dropped since starting treatment. Most people find that setting a rough daily protein target, even an informal one, is enough to prevent the shortfall.
Slow, steady titration also matters. Treatment starts at a low dose, and moving too fast through the schedule before the body has adjusted can intensify the calorie-deficit stress. That titration timing is a clinical decision made by your prescriber, not something to manage independently. If you're already experiencing shedding and wondering whether your current dose is contributing, that is exactly the conversation to have at your next review rather than skipping doses or stopping abruptly.
Most telogen effluvium settles on its own within three to six months, once the body adjusts to its new weight and nutritional intake stabilises. No specific medical treatment is required in straightforward cases. But some situations need a clinician sooner rather than later.
Contact your GP or prescribing clinician if: shedding is severe or accelerating rather than plateauing; you notice patchy or asymmetric loss; loss is accompanied by scalp pain, itching, or skin changes; or you have other symptoms such as fatigue, cold intolerance, or mood changes that suggest an underlying thyroid or iron issue. Hair loss can be the first visible sign of a nutritional deficiency or a thyroid problem unrelated to semaglutide, and treating the root cause resolves it far faster than waiting.
Any suspected side effect from a prescription medicine can be reported directly at the MHRA's Yellow Card scheme, which is how the regulator builds its real-world safety picture. You do not need a clinician to submit a report, patients can do it themselves. The page on more serious semaglutide side effects covers the symptoms that need urgent attention, including pancreatitis signs and allergic reactions, which are distinct from hair thinning in every way.
It is worth being clear about something: the evidence linking semaglutide to hair loss points consistently to weight-loss-related telogen effluvium rather than a direct pharmacological effect on follicles. Studies on bariatric surgery patients show the same pattern at the same timescale, it is a consequence of losing a significant amount of weight quickly, full stop. That does not make it less real or less frustrating, but it does shape how it is managed.
The detailed breakdown of semaglutide and hair loss goes further into the research if you want to read the mechanism in depth. For those considering treatment and weighing up side effects as part of that decision, our prescribers discuss the full picture (including less common effects like this) as a standard part of the free consultation. No question is too minor to raise before you start.
If you want to explore weight-loss treatment options more broadly before committing to a consultation, that overview is a good starting point. The clinical team at nume reviews every consultation personally, a clinician reads your answers on the same day you submit them, which means side-effect concerns are addressed before a prescription is issued, not after.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.